Clene to file accelerated approval NDA for ALS drug in Q3 2026 after FDA confirms data package
Filed May 4, 2026 · Period ending May 4, 2026 · ~1 min read
4 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade CLNN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 2, 2026 5:14 PM